昂利康：西格列汀二甲双胍缓释片完成药品注册

Core Viewpoint - The company, Anglikang (002940.SZ), has received a drug registration certificate from the National Medical Products Administration for its product, Sitagliptin Metformin Extended-Release Tablets, indicating a significant regulatory milestone for the company in the diabetes treatment market [1] Group 1 - The Sitagliptin Metformin Extended-Release Tablets are a compound formulation designed for adult patients with type 2 diabetes who are currently undergoing treatment with both Sitagliptin and Metformin Extended-Release Tablets [1]